SCHEMBL19973508

SCHEMBL19973508

CNC(=O)NC1CCOc2c(C(=O)Nc3ccc(F)c(F)c3)cc([N+](=O)[O-])cc21

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.37
MAPT P10636 7/20 0.37
KMT2A Q03164 6/20 0.37
MEN1 O00255 5/20 0.37
MAPK1 P28482 2/20 0.37
MAOB P27338 1/20 0.37
NPC1 O15118 7/20 0.36
SMN1; SMN2 Q16637 5/20 0.36
LMNA P02545 3/20 0.36
HTT P42858 2/20 0.36
PPARG P37231 1/20 0.36
CASP3 P42574 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
ALDH1A1 P00352 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
TRPV1 Q8NER1 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19973504 1.00 RAB9A (0.37) RAB9AMAPTKMT2AMEN1MAPK1
SCHEMBL19973529 0.90 MAPT (0.39) RAB9AMAPTKMT2AMEN1MAPK1
SCHEMBL19973532 0.90 MAPT (0.39) RAB9AMAPTKMT2AMEN1MAPK1
SCHEMBL21189202 0.90 MAPT (0.37) RAB9AMAPTKMT2AMEN1MAPK1
SCHEMBL19973429 0.85 MAOB (0.39) RAB9AMAPTMAOBNPC1SMN1; SMN2
SCHEMBL19973430 0.85 MAOB (0.39) RAB9AMAPTMAOBNPC1SMN1; SMN2
SCHEMBL19973894 0.84 MAPT (0.35) RAB9AMAPTKMT2AMEN1MAPK1
SCHEMBL19973895 0.84 MAPT (0.35) RAB9AMAPTKMT2AMEN1MAPK1
SCHEMBL19973897 0.84 MAPT (0.35) RAB9AMAPTKMT2AMEN1MAPK1
SCHEMBL19973902 0.83 TRPV1 (0.44) RAB9AMAOBNPC1SMN1; SMN2TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2021-05-11 US disclosed
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2019-07-25 US disclosed
WO-2018052967-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME CBX8, HAVCR2, HCCS RAB9A 1393/4885MAPT 3165/4885KMT2A 155/4885
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same CBX8, HAVCR2, HCCS RAB9A 1393/4885MAPT 3165/4885KMT2A 155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.